Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Novartis leads list of 2012's 20 biggest spenders for R&D
Novartis, Roche Holding and Merck & Co. topped this ranking of biopharmaceutical companies based on spending for research and development last year. Pfizer and Johnson and Johnson came in fourth and fifth, respectively. Also making the top 10 were Sanofi, GlaxoSmithKline, Eli Lilly and Co., AstraZeneca and Abbott Laboratories.
Or we can send an email on your behalf